Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Schwank

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Nature Biomedical Engineering|September 19, 2025
Spatial profiling of gene editing by in situ sequencing in mice and macaquesSharan Janjuha, Tatjana Haenggi, Thomas C Chamberlain, et al.
Genome Biology|May 9, 2025
Predicting adenine base editing efficiencies in different cellular contexts by deep learningLucas Kissling, Amina Mollaysa, Sharan Janjuha, et al.
Science (New York, N.Y.)|February 5, 2026
Programmable genome editing in human cells using RNA-guided bridge recombinasesOana Pelea, András Tálas, Javier Fernández Carrera, et al.
Nature|April 30, 2015
Sequential cancer mutations in cultured human intestinal stem cellsJarno Drost, Richard H van Jaarsveld, Bas Ponsioen, et al.
Science Translational Medicine|May 13, 2026
RNA-LNP-mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type IAndrás Tálas, Eleonora I Ioannidi, Yanik Weber, et al.
Cell Reports|August 24, 2022
SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancerPatrik Simmler, Cédric Cortijo, Lisa Maria Koch, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Cell-stereotyped DNA repair outcomes are widespread during genome editingMoritz F Schlapansky, Markus S Schröder, Antonio J Santinha, et al.
Cell Genomics|February 21, 2022
Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatmentChristian K Hirt, Tijmen H Booij, Linda Grob, et al.
Nature Biomedical Engineering|May 20, 2025
Treatment of a metabolic liver disease in mice with a transient prime editing approachTanja Rothgangl, András Tálas, Eleonora I Ioannidi, et al.
Nature Communications|December 9, 2025
Prime editing of the β<sub>1</sub> adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer's diseaseDesirée Böck, Lisa Tidecks, Maria Wilhelm, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Nature Biomedical Engineering|September 19, 2025
Spatial profiling of gene editing by in situ sequencing in mice and macaquesSharan Janjuha, Tatjana Haenggi, Thomas C Chamberlain, et al.
Genome Biology|May 9, 2025
Predicting adenine base editing efficiencies in different cellular contexts by deep learningLucas Kissling, Amina Mollaysa, Sharan Janjuha, et al.
Science (New York, N.Y.)|February 5, 2026
Programmable genome editing in human cells using RNA-guided bridge recombinasesOana Pelea, András Tálas, Javier Fernández Carrera, et al.
Nature|April 30, 2015
Sequential cancer mutations in cultured human intestinal stem cellsJarno Drost, Richard H van Jaarsveld, Bas Ponsioen, et al.
Science Translational Medicine|May 13, 2026
RNA-LNP-mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type IAndrás Tálas, Eleonora I Ioannidi, Yanik Weber, et al.
Cell Reports|August 24, 2022
SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancerPatrik Simmler, Cédric Cortijo, Lisa Maria Koch, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Cell-stereotyped DNA repair outcomes are widespread during genome editingMoritz F Schlapansky, Markus S Schröder, Antonio J Santinha, et al.
Cell Genomics|February 21, 2022
Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatmentChristian K Hirt, Tijmen H Booij, Linda Grob, et al.
Nature Biomedical Engineering|May 20, 2025
Treatment of a metabolic liver disease in mice with a transient prime editing approachTanja Rothgangl, András Tálas, Eleonora I Ioannidi, et al.
Nature Communications|December 9, 2025
Prime editing of the β<sub>1</sub> adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer's diseaseDesirée Böck, Lisa Tidecks, Maria Wilhelm, et al.
Pageof 7